An illustrated case of doxorubicin-induced radiation recall dermatitis and a review of the literature

Netherlands Journal of Medicine

Volumn 69, Issue 2, 2011, Pages 72-75

  Haas, R L M ^a   de Klerk, G ^b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b Department of Internal Medicine and Oncology ^*  (Netherlands)

Author keywords

Doxorubicin; Radiotherapy; Recall dermatitis

Indexed keywords

ALPHA2B INTERFERON; ANGIOPEPTIN; ARSENIC TRIOXIDE; BEVACIZUMAB; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; GATIFLOXACIN; GEFITINIB; GEMCITABINE; IDARUBICIN; LEVOFLOXACIN; METHOTREXATE; OXALIPLATIN; PACLITAXEL; PEMETREXED; PROGESTERONE RECEPTOR; SIMVASTATIN; TAMOXIFEN; TRASTUZUMAB; VINBLASTINE;

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CASE REPORT; DRUG DOSE INCREASE; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; RADIATION DERMATITIS; RARE DISEASE;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; RADIODERMATITIS;

EID: 79952948418     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. D'Angio GJ. Clinical and biologic studies of actinomycin D roentgen irradiation. Am J Roentgenol. 1962;87:106-9.
2. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_ 8.5x11.pdf.
3. http://www.adjuvantonline.com/index.jsp.
4. Camidge R.,Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59:237-45.
5. Mayer EG, Poulter CA, Aristizabal SA. Complications of irradiation related to apparent drug potentiation by adriamycin. Int J Radiat Oncol Biol Phys. 1976;1:1179-88.
6. Burdon J, Bell R, Sullivan J, Henderson M. Adriamycin-induced recall phenomenon 15 years after radiotherapy. J Am Med Assoc. 1978;239:1.
7. Caloglu M, Yurut-Caloglu V, Cosar-Alas R, Saynak M, Karagol H, Uzal C. An ambiguous phenomenon of radiation and drugs: recall reactions. Onkologie. 2007;30: 209-14.
8. Culp LR, Pou AM, Jones DV, Bayouth J, Sanguineti G. A case of radiation recall mucositis associated with docetaxel. Head Neck. 2004;26:197-200.
9. Miura G, Matsumoto T, Tanaka N, Emoto T, Kawamura T, Matsunaga N. Two cases of radiation myositis probably induced by recall phenomenon. Nippon Igaku Hoshasen Gakkai Zasshi. 2003;63:420-2.
10. Gabel C, Eifel PJ, Tornos C, Burke TW. Radiation recall reaction to idarubicin resulting in vaginal necrosis. Gynecol Oncol. 1995;57:266-9.
11. Ma LD, Taylor GA, Wharam MD, Wiley JM. ''Recall'' pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology. 1993;187:465-7.
12. Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26:2085-92.
13. Kang SK. Images in clinical medicine. Radiation recall reaction after antimicrobial therapy. N Engl J Med. 2006;354:622.
14. Demirel C, Kilciksiz S, Evirgen-Ayhan S, Gurgul S, Erdal N. The preventive effect of N-acetylcysteine on radiation-induced dermatitis in a rat model. J BUON. 2010;15:577-82.
15. Gzell CE, Carroll SL, Suchowerska N, Beith J, Tan K, Scolyer RA. Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin. Cancer Invest. 2009;27:397-401.
16. Muggia FM. Radiation recall dermatitis induced by pegylated liposomal doxorubicin. Anticancer Drugs. 2004;15:35.
17. Jimeno A, Ciruelos EM, Castellano D, Caballero B, Rodriguez-Peralto JL, Cortés-Funes H. Radiation recall dermatitis induced by pegylated liposomal doxorubicin. Anticancer Drugs. 2003;14:575-6.
18. Vegesna V, Withers HR, McBride WH, Holly FE. Adriamycin-induced recall of radiation pneumonitis and epilation in lung and hair follicles of mouse. Int J Radiat Oncol Biol Phys. 1992;23:977-81.
19. Chen SS, Strauss JB, Shah AP, Rao RD, Bernard DA, Griem KL. Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy. 2009;8:331-4.
20. Hird AE, Wilson J, Symons S, Sinclair E, Davis M, Chow E. Radiation recall dermatitis: case report and review of the literature. Curr Oncol. 2008;15:53-62.
21. Mizumoto M, Harada H, Asakura H, Zenda S, Fuji H, Murayama S, et al. Frequency and characteristics of docetaxel-induced radiation recall phenomenon. Int J Radiat Oncol Biol Phys. 2006;66:1187-91.
22. Borgia F, Guarneri C, Guarneri F, Vaccaro M. Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug? Br J Dermatol. 2005;153:674-5.
23. Kandemir EG, Karabudak O, Maydagli A. Docetaxel-induced radiation recall dermatitis. Swiss Med Wkly. 2005;135:34-5.
24. Piroth MD, Krempien R, Wannenmacher M, Zierhut D. Radiation recall dermatitis from docetaxel. Onkologie. 2002;25:438-40.
25. Magné N, Benezery K, Otto J, Namer M, Lagrange JL. Radiation recall dermatitis after docetaxel and external beam radiotherapy. Report of two cases and review of the literature. Cancer Radiother. 2002;6:281-4.
26. Giesel BU, Kutz GG, Thiel HJ. Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature. Strahlenther Onkol. 2001;177:487-93.
27. Camidge DR, Kunkler IH. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol (R Coll Radiol). 2000;12:272-3.
28. Schwarte S, Wagner K, Karstens JH, Bremer M. Radiation recall pneumonitis induced by gemcitabine. Strahlenther Onkol. 2007;183:215-7.
29. Squire S, Chan M, Feller E, Mega A, Gold R. An unusual case of gemcitabine-induced radiation recall. Am J Clin Oncol. 2006;29:636.
30. Pinson PJ, Griep C, Sanders WH, Lelie B. [Myositis as a 'radiation-recall phenomenon' following palliative chemotherapy with carboplatingemcitabin for non-small-cell pulmonary carcinoma]. Ned Tijdschr Geneeskd. 2006;150:1891-4.
31. Fakih MG. Gemcitabine-induced rectus abdominus radiation recall. JOP. 2006;7:306-10.
32. Marisavljevíc D, Risti ́c B, Hajder J. Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma. Am J Hematol. 2005;80:91.
33. Schwartz BM, Khuntia D, Kennedy AW, Markman M. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecol Oncol. 2003;91:421-2.
34. Jeter MD, Jänne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002;53:394-400.
35. Bar-Sela G, Beny A, Bergman R, Kuten A. Gemcitabine-induced radiation recall dermatitis: case report. Tumori. 2001;87:428-30.
36. Fogarty G, Ball D, Rischin D. Radiation recall reaction following gemcitabine. Lung Cancer. 2001;33:299-302.
37. Kundak I, Oztop I, Soyturk M, Ozcan MA, Yilmaz U, Meydan N, et al. Paclitaxel-carboplatin induced radiation recall colitis. Tumori. 2004;90:256-8.
38. Bokemeyer C, Lampe C, Heneka M, Schabet M, Bamberg M, Kanz L. Paclitaxel-induced adiation recall dermatitis. Ann Oncol. 1996 7:755-6.
39. Camidge DR. Methotrexate-induced radiation recall. Am J Clin Oncol. 2001;24:211-3.
40. Kharfan Dabaja MA, Morgensztern D, Markoe AM, Bartlett-Pandite L. Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease. Am J Clin Oncol. 2000;23:531-3.
41. Kundranda MN, Daw HA. Tamoxifen-induced radiation recall dermatitis. Am J Clin Oncol. 2006;29:637-8.
42. Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF. Tamoxifen-induced radiation recall dermatitis. Breast J. 2004;10:170-1.
43. Boström A, Sjölin-Forsberg G, Wilking N, Bergh J. Radiation recall, another call with tamoxifen. Acta Oncol. 1999;38:955-9.
44. Parry BR. Radiation recall induced by tamoxifen. Lancet. 1992;340: 49.
45. Nemechek PM, Corder MC. Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer. 1992;70:1605-6.
46. Kennedy RD, McAleer JJ. Radiation recall dermatitis in a patient treated with dacarbazine. Clin Oncol. 2001;13:470-2.
47. Law AB, Junor EJ. Chemotherapy-induced recall of cetuximab and radiation skin reaction. Clin Oncol. 2009;21:77-8.
48. Mievis C, Jansen N, Schleich F, Gennigens C, Rorive A, Jérusalem G, et al. Radiation recall dermatitis after oral cyclophosphamide. Rev Med Liege. 2009;64:179-81.
49. Borroni G, Vassallo C, Brazzelli V, Martinoli S, Ardigò M, Alessandrino PE, et al. Radiation recall dermatitis, panniculitis, and myositis following cyclophosphamide therapy: histopathologic findings of a patient affected by multiple myeloma. Am J Dermatopathol. 2004;26:213-6.
50. Ghosal N, Misra V. A Case of capecitabine-induced hyperpigmentation and radiation recall phenomenon. Clin Oncol. 2009;21(8):632.
51. Saif MW, Black G, Johnson M, Russo S, Diasio R. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. Cancer Chemother Pharmacol. 2006;58:771-5.
52. Ortmann E, Hohenberg G. Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine. J Clin Oncol. 2002;20:3029-30.
53. Saif MW, Ramos J, Knisely J. Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer. JOP. 2008;9:744-7.
54. Shrimali RK, McPhail NJ, Correa PD, Fraser J, Rizwanullah M. Trastuzumab-induced Radiation Recall Dermatitis - First Reported Case. Clin Oncol. 2009;21(8):634-5.
55. Khanfir K, Anchisi S. Pemetrexed-associated radiation recall dermatitis. Acta Oncol. 2008;47:1607-8.
56. Barlési F, Tummino C, Tasei AM, Astoul P. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Lung Cancer. 2006;54:423-5.
57. Hureaux J, Le Guen Y, Tuchais C, Savary L, Urban T. Radiation recall dermatitis with pemetrexed. Lung Cancer. 2005;50:255-8.
58. Jain S, Agarwal J, Laskar S, Gupta T, Shrivastava S. Radiation recall dermatitis with gatifloxacin: a review of literature. J Med Imaging Radiat Oncol. 2008;52:191-3.
59. Cho S, Breedlove JJ, Gunning ST. Radiation recall reaction induced by levofloxacin. J Drugs Dermatol. 2008;7:64-7.
60. Bauzá A, Del Pozo LJ, Escalas J, Mestre F. Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide. Br J Dermatol. 2007;157:1061-3.
61. Miya T, Ono Y, Tanaka H, Koshiishi Y, Goya T. Radiation recall pneumonitis induced by Gefitinib (Iressa): a case report. Nihon Kokyuki Gakkai Zasshi. 2003;41:565-8.
62. Keung YK, Lyerly ES, Powell BL. Radiation recall phenomenon associated with arsenic trioxide. Leukemia. 2003;17:1417-8.
63. Thomas R, Stea B. Radiation recall dermatitis from high-dose interferon alfa-2b. J Clin Oncol. 2002;20:355-7.
64. Camidge R. Oxaliplatin-induced radiation recall: timing not a problem. Clin Oncol. 2001;13:236.
65. Chan RT, Au GK, Ho JW, Chu KW. Radiation recall with oxaliplatin: report of a case and a review of the literature. Clin Oncol. 2001;13:55-7.
66. Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol. 1995;7:325-6.
67. Stelzer KJ, Griffin TW, Koh WJ. Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer. 1993;71:1322-5.